Fidelity Investments’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16
| Closed | -$362 | – | 5499 |
|
|
2024
Q4 | $362 | Buy |
16
+15
| +1,500% | +$339 | ﹤0.01% | 5013 |
|
|
2024
Q3 | $25 | Sell |
1
-22
| -96% | -$550 | ﹤0.01% | 5302 |
|
|
2024
Q2 | $532 | Sell |
23
-79
| -77% | -$1.83K | ﹤0.01% | 4854 |
|
|
2024
Q1 | $2.46K | Buy |
+102
| New | +$2.46K | ﹤0.01% | 4656 |
|
|
2023
Q4 | – | Sell |
-1
| Closed | -$20 | – | 5539 |
|
|
2023
Q3 | $20 | Buy |
+1
| New | +$20 | ﹤0.01% | 5089 |
|
|
2023
Q2 | – | Sell |
-69
| Closed | -$1.61K | – | 5489 |
|
|
2023
Q1 | $1.61K | Buy |
69
+68
| +6,800% | +$1.58K | ﹤0.01% | 4670 |
|
|
2022
Q4 | $25 | Buy |
+1
| New | +$25 | ﹤0.01% | 5070 |
|
|
2022
Q3 | – | Sell |
-8
| Closed | – | – | 5146 |
|
|
2022
Q2 | $0 | Sell |
8
-133
| -94% | – | ﹤0.01% | 5203 |
|
|
2022
Q1 | $5K | Sell |
141
-688
| -83% | -$24.4K | ﹤0.01% | 4436 |
|
|
2021
Q4 | $36K | Buy |
829
+83
| +11% | +$3.6K | ﹤0.01% | 3309 |
|
|
2021
Q3 | $38K | Buy |
746
+89
| +14% | +$4.53K | ﹤0.01% | 3280 |
|
|
2021
Q2 | $34K | Sell |
657
-59
| -8% | -$3.05K | ﹤0.01% | 3248 |
|
|
2021
Q1 | $32K | Buy |
+716
| New | +$32K | ﹤0.01% | 3143 |
|